Parmax Pharma

{
  "main_header": {
    "sid": 1002724,
    "name": "Parmax Pharma",
    "stock_name": "Parmax Pharma",
    "full_name": "Parmax Pharma Ltd",
    "name_url": "stocks-analysis/parmax-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.02",
    "chg": -0.98,
    "chgp": "-3.16%",
    "dir": -1,
    "prev_price": "31.00",
    "mcapval": "12.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540359,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE240T01014",
    "curr_date": "Apr 30",
    "curr_time": "",
    "bse_nse_vol": "1.35 k",
    "exc_status": "Active",
    "traded_date": "Apr 30, 2026",
    "traded_date_str": "2026 04 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/parmax-pharma-1002724-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Parmax Pharma Ltd Falls to 52-Week Low of Rs 22.6 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-stock-falls-to-52-week-low-of-rs226-3915864",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParmaxPharmaLtd_priceRelatedfactors_3915864.png",
        "date": "2026-03-25 10:02:56",
        "description": ""
      },
      {
        "title": "Parmax Pharma Ltd Falls to 52-Week Low of Rs 24.5 Amidst Continued Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-falls-to-52-week-low-of-rs-245-amidst-continued-weakness-3898506",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParmaxPharmaLtd_priceRelatedfactors_3898506.png",
        "date": "2026-03-18 10:04:09",
        "description": "Parmax Pharma Ltd, a micro-cap entity in the Pharmaceuticals & Biotechnology sector, has declined sharply to a new 52-week low of Rs.24.5, marking a significant drop of 11.71% in today’s trading session. This fresh low underscores the stock’s ongoing underperformance relative to its sector and broader market indices."
      },
      {
        "title": "Parmax Pharma Ltd Falls to 52-Week Low of Rs 25 Amidst Weak Financials",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-falls-to-52-week-low-of-rs-25-amidst-weak-financials-3887189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParmaxPharmaLtd_priceRelatedfactors_3887189.png",
        "date": "2026-03-12 14:57:13",
        "description": "Parmax Pharma Ltd’s shares declined sharply to a new 52-week low of Rs.25 on 12 Mar 2026, marking a significant downturn amid ongoing financial headwinds and sector underperformance. The stock’s recent volatility and sustained downward trend reflect persistent challenges in the company’s financial metrics and market positioning."
      },
      {
        "title": "Parmax Pharma Q3 FY26: Mounting Losses Deepen as Revenue Plummets 72% YoY",
        "link": "https://www.marketsmojo.com/news/result-analysis/parmax-pharma-q3-fy26-mounting-losses-deepen-as-revenue-plummets-72-yoy-3842936",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ParmaxPharma_quaterlyResult_3842936.png",
        "date": "2026-02-16 22:05:05",
        "description": "Parmax Pharma Ltd., a micro-cap pharmaceutical company specialising in Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations (CMO), has reported deeply concerning financial results for Q3 FY26, with net losses widening to ₹0.73 crores whilst revenues collapsed 72.74% year-on-year to ₹2.53 crores. The company, trading at ₹32.00 with a market capitalisation of just ₹12.00 crores, has now recorded consecutive quarterly losses throughout FY26, raising serious questions about operational viability and management execution."
      },
      {
        "title": "When is the next results date for Parmax Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-parmax-pharma-ltd-3833797",
        "imagepath": "",
        "date": "2026-02-11 23:17:17",
        "description": "The next results date for Parmax Pharma Ltd is scheduled for 14 February 2026...."
      }
    ],
    "total": 116,
    "sid": "1002724",
    "stock_news_url": "https://www.marketsmojo.com/news/parmax-pharma-1002724"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "02-May-2026",
      "details": "Re-appointment of Mr. Umang Gosalia as a Managing Director of the Company",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Parmax Pharma Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24231GJ1994PLC023504</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>7.92</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: BHAKTI AGHERA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: CS@PARMAXPHARMA.COM</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: UMANG GOSALIA <br/> Designation: MANAGING DIRECTOR <br/> EmailId: INFO@PARMAXOHARMA.OCM</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "17-Apr-2026",
      "details": "RTA Compliance certificate for Quarter ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Parmax Pharma Ltd Falls to 52-Week Low of Rs 22.6 as Sell-Off Deepens

2026-03-25 10:02:56

Read full news article

Parmax Pharma Ltd Falls to 52-Week Low of Rs 24.5 Amidst Continued Weakness

2026-03-18 10:04:09

Parmax Pharma Ltd, a micro-cap entity in the Pharmaceuticals & Biotechnology sector, has declined sharply to a new 52-week low of Rs.24.5, marking a significant drop of 11.71% in today’s trading session. This fresh low underscores the stock’s ongoing underperformance relative to its sector and broader market indices.

Read full news article

Parmax Pharma Ltd Falls to 52-Week Low of Rs 25 Amidst Weak Financials

2026-03-12 14:57:13

Parmax Pharma Ltd’s shares declined sharply to a new 52-week low of Rs.25 on 12 Mar 2026, marking a significant downturn amid ongoing financial headwinds and sector underperformance. The stock’s recent volatility and sustained downward trend reflect persistent challenges in the company’s financial metrics and market positioning.

Read full news article

Parmax Pharma Q3 FY26: Mounting Losses Deepen as Revenue Plummets 72% YoY

2026-02-16 22:05:05

Parmax Pharma Ltd., a micro-cap pharmaceutical company specialising in Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations (CMO), has reported deeply concerning financial results for Q3 FY26, with net losses widening to ₹0.73 crores whilst revenues collapsed 72.74% year-on-year to ₹2.53 crores. The company, trading at ₹32.00 with a market capitalisation of just ₹12.00 crores, has now recorded consecutive quarterly losses throughout FY26, raising serious questions about operational viability and management execution.

Read full news article

When is the next results date for Parmax Pharma Ltd?

2026-02-11 23:17:17

The next results date for Parmax Pharma Ltd is scheduled for 14 February 2026....

Read full news article

View All News